相关实验视频

Updated: Nov 3, 2025

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection

Published on: June 5, 2021

通过中和单克隆抗体应对COVID-19

Davide Corti¹, Lisa A Purcell², Gyorgy Snell³

¹Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.

|June 4, 2021

概括

单克隆抗体 (mAbs) 对像COVID-19这样的传染病有效. 从开发这些抗体疗法中得到的教训将为未来的传染病爆发提供治疗.

科学领域:

免疫学
病毒学
药理学

背景情况:

单克隆抗体 (mAbs) 已经改变了癌症,自身免疫和炎症疾病的治疗方法.
mAbs正在成为传染病的关键治疗策略.
在mAb隔离技术的快速进步使其能够对新出现的病原体进行使用.

研究的目的:

提供SARS-CoV-2中和单克隆抗体 (mAbs) 的概述.
讨论这些mAbs的起源,特异性,结构和作用机制.
审查它们对变种的耐药性和临床试验状态.

主要方法:

科学文献和临床试验数据的审查.
分析mAb特征,包括起源,特异性和结构.
对抗病毒和免疫机制的评估,以及对SARS-CoV-2变种的耐药性.

主要成果:

目前已开发出前所未有的数量mAbs用于COVID-19治疗.
这些mAbs表现出不同的起源,特点和作用机制.
了解mAb对变体的耐药性对于治疗疗效至关重要.

结论:

单克隆抗体是对抗传染病的强大工具,COVID-19就是一个例子.
从COVID-19 mAb开发中获得的经验将加速未来的传染病治疗方法.
需要进一步研究mAb的疗效,耐药性和临床应用.

关键词:

美国冠状病毒单克隆抗体中和治疗药物

更多相关视频

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

相关概念视频

Antibody Actions

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

Humoral Immune Responses

Humoral Immune Responses